Presentations

08:00

Saroglitazar improves post-liver transplant metabolic associated steatotic liver disease- A randomized controlled trial- interim analysis

Dinesh Jothimani (IN)

Bio Abstract

08:10

Harnessing the estrogen-PARP axis: A key to enhancing liver graft survival and combating fibrosis

Binnaz Handan Ozdemir (TR)

Bio Abstract

08:17

Early Post-Transplant Recipient-Derived Cell-Free DNA Predicts One-Year Graft Survival in Liver Transplant Recipients

Eun-Ki Min (KR)

Bio Abstract

08:24

25 years of pregnancy outcomes after liver transplantation

Lisa A. Coscia (US)

Bio Abstract

08:31

Temporal changes in graft failure over three decades of liver transplantation: Insights from ultra-long-term outcomes with well-maintained follow-up at a single center

Masaaki Hirata (JP)

Bio Abstract

08:38

Post-transplant MASLD does not adversely affect long-term survival or cardiometabolic outcomes following liver transplantation

Ki Sang Jung (KR)

Bio Abstract

08:43

Liver Transplantation After TARE Downstaging in Advanced Hepatocellular Carcinoma: A Single-Center Experience

Dahyun Jung (KR)

Bio Abstract

08:48

A 25-year experience of a “free of cost” dedicated living donor clinic in a low-middle-income countries. An insight into impediments to compliance in regular yearly follow-up and their impact on long-term outcomes

Mirza Zafar (PK)

Bio Abstract